Projects
An overview of our (international) projects and collaborations
SPIDERR-Horizon EU
Lead: Rachel Knevel, Dept of Rheumatology LUMC, the Netherlands
Our role: Project lead
Aim: Aim: SPIDeRR aims to disentangle the real-life complexity of early diagnosis of rheumatic diseases by considering the complete web of factors influencing patients’ symptoms. It will deliver: -a symptom checker for patients, -a decision support tool for (primary) care providers providing guiding additional examination and referral decisions -a patient-patient similarity network to optimise diagnostic groups in rheumatology and support treatment decision
Digiprevent - EITHealth
Lead: Lars Klareskog, Dept of Rheumatology Karolinska Institute Zweden
Our role: Implementation
Aim: DigiPrevent enables personalised prevention in RA, combined with much earlier treatment if arthritis ensues, through a new digital screening procedure, Rheumatic and a blood based diagnostic tool, Rheuma-multiplex.
SQUEEZE - Horizon EU
Lead: Daniel Aletaha, Dept of Rheumatology, Vienna
Our role: Analytic lead
Aim: SQUEEZE integrates to validate clinical, laboratory, molecular, digital and behavioural biomarkers to enable the recognition of patients with high likelihood of response to treatment and the selection of the drug with highest chance of benefit for an individual patient; and as such improve efficacy and safety of existing therapies (by squeezing the most out of existing drugs) in synergy with other EU-wide activities
RTCure - IMI
Lead: Lars Klareskog, Dept of Rheumatology Karolinska Institute Zweden
Our role: Bioinformatic lead
Aim: Prevent RA or its progression by inhibiting the expansion of pathogenic autoimmune responses through immune tolerising treatments.